Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Boehringer Ingelheim synthesizes new GPR119 receptor agonists

July 2, 2013

MOD-6030 shows promise in animal models of obesity and type 2 diabetes

July 2, 2013

First approval achieved for gout and hyperuricemia therapeutic in Japan

July 1, 2013

Amicus to develop chaperone-advanced replacement therapy for MPS I

July 1, 2013

Lyxumia approved in Japan for type 2 diabetes

June 28, 2013

Researchers at Janssen Pharmaceutica design new stearoyl-CoA desaturase inhibitors

June 28, 2013

Application filed in Japan to expand Regpara indication

June 28, 2013

Eisai submits NDS for Belviq in Canada

June 28, 2013

Novel, cost-effective nanoparticle technology for male contraception

June 28, 2013

LY-2405319 as a potential new treatment for metabolic disorders

June 28, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...